CS241052B2 - Method of 4-methyl-6-phenylpyridazine derivatives prepation - Google Patents

Method of 4-methyl-6-phenylpyridazine derivatives prepation Download PDF

Info

Publication number
CS241052B2
CS241052B2 CS825912A CS591282A CS241052B2 CS 241052 B2 CS241052 B2 CS 241052B2 CS 825912 A CS825912 A CS 825912A CS 591282 A CS591282 A CS 591282A CS 241052 B2 CS241052 B2 CS 241052B2
Authority
CS
Czechoslovakia
Prior art keywords
group
methyl
compound
reaction
formula
Prior art date
Application number
CS825912A
Other languages
Czech (cs)
English (en)
Other versions
CS591282A2 (en
Inventor
Camille-Georges Wermuth
Kathlen Biziere
Horace Davi
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Priority to CS825912A priority Critical patent/CS572782A2/cs
Priority to CS845726A priority patent/CS241093B2/cs
Priority to CS845727A priority patent/CS241094B2/cs
Publication of CS591282A2 publication Critical patent/CS591282A2/cs
Publication of CS241052B2 publication Critical patent/CS241052B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22Nitrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CS825912A 1981-08-10 1982-08-09 Method of 4-methyl-6-phenylpyridazine derivatives prepation CS241052B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CS825912A CS572782A2 (en) 1981-08-10 1982-08-09 Zpusob pripravy 4 methyl 6 fenylpyridazinovych derivatu
CS845726A CS241093B2 (cs) 1981-08-10 1982-08-09 Způsob přípravy 3-[2-(3-oxo-4-morfolinyl)ethylamino] -4-methyl-6-fenylpyridazinu
CS845727A CS241094B2 (cs) 1981-08-10 1984-07-25 Způsob přípravy 4-methyl-S-fenylpyridazinových derivátů

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8115435A FR2510997A1 (fr) 1981-08-10 1981-08-10 Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant

Publications (2)

Publication Number Publication Date
CS591282A2 CS591282A2 (en) 1985-06-13
CS241052B2 true CS241052B2 (en) 1986-03-13

Family

ID=9261319

Family Applications (1)

Application Number Title Priority Date Filing Date
CS825912A CS241052B2 (en) 1981-08-10 1982-08-09 Method of 4-methyl-6-phenylpyridazine derivatives prepation

Country Status (29)

Country Link
US (3) US4576946A (es)
EP (1) EP0072299B1 (es)
JP (1) JPS5838262A (es)
KR (1) KR880002710B1 (es)
AT (1) ATE24317T1 (es)
AU (1) AU548029B2 (es)
CA (1) CA1180704A (es)
CS (1) CS241052B2 (es)
DD (3) DD213212A5 (es)
DE (1) DE3274737D1 (es)
DK (1) DK148654C (es)
EG (1) EG15922A (es)
ES (1) ES514854A0 (es)
FI (1) FI74462C (es)
FR (1) FR2510997A1 (es)
GR (1) GR76235B (es)
HU (1) HU190695B (es)
IE (1) IE53611B1 (es)
IL (1) IL66423A0 (es)
MA (1) MA19561A1 (es)
NO (1) NO157141C (es)
NZ (1) NZ201530A (es)
OA (1) OA07178A (es)
PH (1) PH17883A (es)
PL (3) PL137201B1 (es)
PT (1) PT75371B (es)
SU (2) SU1366056A3 (es)
YU (3) YU171782A (es)
ZA (1) ZA825516B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2539741A1 (fr) * 1983-01-21 1984-07-27 Sanofi Sa Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
US4565814A (en) * 1983-01-28 1986-01-21 Sanofi Pyridazine derivatives having a psychotropic action and compositions
FR2601011B1 (fr) * 1986-07-03 1988-10-28 Sanofi Sa Nouveaux derives tricycliques agonistes des recepteurs cholinergiques et medicaments en contenant
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
US5656631A (en) * 1989-02-07 1997-08-12 Sanofi Pyridazine derivatives
FR2642648B1 (fr) * 1989-02-07 1991-06-21 Sanofi Sa Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique
PT93060B (pt) 1989-02-07 1995-12-29 Sanofi Sa Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem
JP3553142B2 (ja) * 1994-07-29 2004-08-11 花王株式会社 4級アンモニウム塩の製造方法及び中間体ジアミノアルコール
JP5221952B2 (ja) * 2004-05-08 2013-06-26 ノバルティス・インターナショナル・ファーマシューティカル・リミテッド 3−アリール−5,6−ジ置換ピリダジン類
EP1741709A1 (en) * 2005-06-28 2007-01-10 Sanofi-Aventis Deutschland GmbH Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
AR081626A1 (es) * 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
MA41598A (fr) * 2015-02-25 2018-01-02 Constellation Pharmaceuticals Inc Composés thérapeutiques de pyridazine et leurs utilisations
AR119731A1 (es) 2019-05-17 2022-01-05 Novartis Ag Inhibidores del inflamasoma nlrp3

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1345880A (en) * 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives
FR2388799A1 (fr) * 1977-04-28 1978-11-24 Rolland Sa A Derives de pyridazinone, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
DK148654B (da) 1985-08-26
EP0072299B1 (fr) 1986-12-17
JPS5838262A (ja) 1983-03-05
DK357482A (da) 1983-02-11
DK148654C (da) 1986-02-17
YU209684A (en) 1985-04-30
FI74462C (fi) 1988-02-08
EG15922A (en) 1986-06-30
SU1366056A3 (ru) 1988-01-07
CA1180704A (en) 1985-01-08
NO157141C (no) 1988-01-27
NO822705L (no) 1983-02-11
MA19561A1 (fr) 1983-04-01
YU171782A (en) 1985-04-30
YU209784A (en) 1985-04-30
FI74462B (fi) 1987-10-30
FR2510997A1 (fr) 1983-02-11
PL137262B1 (en) 1986-05-31
KR840001146A (ko) 1984-03-28
PL137201B1 (en) 1986-05-31
JPH0417950B2 (es) 1992-03-26
PT75371B (en) 1984-12-10
US4576946A (en) 1986-03-18
KR880002710B1 (ko) 1988-12-26
US4514397A (en) 1985-04-30
EP0072299A3 (en) 1984-01-11
AU8661982A (en) 1983-02-17
US4677106A (en) 1987-06-30
FI822767L (fi) 1983-02-11
FR2510997B1 (es) 1984-02-10
NO157141B (no) 1987-10-19
FI822767A0 (fi) 1982-08-09
IE821821L (en) 1983-02-10
ES8305735A1 (es) 1983-05-01
IL66423A0 (en) 1982-11-30
IE53611B1 (en) 1988-12-21
ATE24317T1 (de) 1987-01-15
ZA825516B (en) 1983-06-29
HU190695B (en) 1986-10-28
PL243377A1 (en) 1984-04-24
PL237837A1 (en) 1984-05-07
GR76235B (es) 1984-08-04
PH17883A (en) 1985-01-21
DE3274737D1 (en) 1987-01-29
DD213213A5 (de) 1984-09-05
PL243376A1 (en) 1984-04-24
CS591282A2 (en) 1985-06-13
EP0072299A2 (fr) 1983-02-16
PT75371A (en) 1982-09-01
DD213212A5 (de) 1984-09-05
DD209453A5 (de) 1984-05-09
PL137265B1 (en) 1986-05-31
AU548029B2 (en) 1985-11-21
ES514854A0 (es) 1983-05-01
OA07178A (fr) 1984-04-30
NZ201530A (en) 1985-05-31
SU1356961A3 (ru) 1987-11-30

Similar Documents

Publication Publication Date Title
CS241052B2 (en) Method of 4-methyl-6-phenylpyridazine derivatives prepation
SU1140685A3 (ru) Способ получени замещенных производных пиридазина
WO1994014780A1 (en) Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors
CS239929B2 (en) Processing of pyridazine derivatives
CA1217490A (en) Heterocyclic compounds, process for preparing them and the drugs containing them, active on the central nervous system
US4540696A (en) 1-Piperazinyl 4-phenylquinazoline compounds having antidepressant properties and drugs containing same
IE53653B1 (en) Derivatives of 4-phenyl quinazoline active on the central nervous system
CA1259990A (en) Process for the preparation of thiadiazole derivatives active on the central nervous system
CS241093B2 (cs) Způsob přípravy 3-[2-(3-oxo-4-morfolinyl)ethylamino] -4-methyl-6-fenylpyridazinu
JPS6228146B2 (es)
FI74463B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 3-amino-4-metyl-6-fenylpyridazinderivat.
DK149531B (da) Analogifremgangsmaade til fremstilling af 3-(2-(3-oxo-4-morpholinyl)-ethylamino)-4-methyl-6-phenyl-pyridazinderivater eller farmaceutisk acceptable syreadditionssalte deraf
EP0221820A1 (fr) Dérivés de l'imino-3 pyridazine, procédé d'obtention et compositions pharmaceutiques en contenant
NO158872B (no) Analogifremgangsmaate for fremstilling av 4-metyl-6-fenylpyridazin-derivater.